FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

773875006: Antiemetic therapeutic role (role)

Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726850010 Antiemetic therapeutic role (role) en Fully specified name Active Case insensitive SNOMED CT core
3726851014 Antiemetic therapeutic role en Synonym Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiemetic therapeutic role Is a Therapeutic role true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Dronabinol-containing product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron-containing product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron-containing product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron-containing product Plays role True Antiemetic therapeutic role Inferred relationship Some
Rolapitant only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron only product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron only product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron only product in transdermal dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Rolapitant only product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Rolapitant only product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron (as granisetron hydrochloride) 1 mg oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron (as granisetron hydrochloride) 2 mg oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Rolapitant-containing product Plays role True Antiemetic therapeutic role Inferred relationship Some
Rolapitant-containing product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Rolapitant-containing product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron-containing product in transdermal dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron 129.167 microgram/hour prolonged-release transdermal patch Plays role True Antiemetic therapeutic role Inferred relationship Some
Granisetron (as granisetron hydrochloride) 200 microgram/mL oral solution Plays role True Antiemetic therapeutic role Inferred relationship Some
Scopolamine butylbromide 10 mg oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine hydrobromide 300 microgram oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine only product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine only product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine only product in transdermal dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine butylbromide 20 mg/mL solution for injection Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine hydrobromide 600 microgram/mL solution for injection Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine hydrobromide 400 microgram/mL solution for injection Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine hydrobromide 400 microgram oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron-containing product in oropharyngeal dose form Plays role False Antiemetic therapeutic role Inferred relationship Some
Ondansetron-containing product Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron-containing product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron-containing product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron-containing product in rectal dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Palonosetron only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Netupitant and palonosetron only product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron only product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron only product in oromucosal dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron only product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron only product in rectal dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Palonosetron only product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosnetupitant- and palonosetron-containing product Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosnetupitant and palonosetron only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosnetupitant- and palonosetron-containing product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosnetupitant- and palonosetron-containing product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosnetupitant and palonosetron only product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosnetupitant and palonosetron only product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 2 mg/mL solution for injection Plays role True Antiemetic therapeutic role Inferred relationship Some
Palonosetron (as palonosetron hydrochloride) 50 microgram/mL solution for injection Plays role True Antiemetic therapeutic role Inferred relationship Some
Netupitant and palonosetron only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 8 mg oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible film Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible film Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron 16 mg rectal suppository Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron hydrochloride 24 mg oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Palonosetron-containing product Plays role True Antiemetic therapeutic role Inferred relationship Some
Netupitant- and palonosetron-containing product Plays role True Antiemetic therapeutic role Inferred relationship Some
Netupitant- and palonosetron-containing product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 800 microgram/mL oral solution Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron-containing product in oromucosal dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Palonosetron-containing product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Cinnarizine only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Amisulpride only product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Amisulpride-containing product in parenteral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Cinnarizine 25 mg oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Some
Aprepitant 40 mg oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone-containing product Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone 1 mg oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone only product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone only product Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone 2 mg oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone 500 microgram oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone 250 microgram oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Some
Nabilone-containing product in oral dose form Plays role True Antiemetic therapeutic role Inferred relationship Some
Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for injection Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron 4 mg oral lyophilisate Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron 8 mg oral lyophilisate Plays role True Antiemetic therapeutic role Inferred relationship Some
Aprepitant 125 mg powder for oral suspension sachet Plays role True Antiemetic therapeutic role Inferred relationship Some
Aprepitant 165 mg oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosaprepitant (as fosaprepitant dimeglumine) 150 mg powder for solution for infusion vial Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion vial Plays role True Antiemetic therapeutic role Inferred relationship Some
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial Plays role True Antiemetic therapeutic role Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 2 mg/mL solution for infusion and/or injection Plays role True Antiemetic therapeutic role Inferred relationship Some

Start Page 2 of 2

Reference Sets

Qualifier value foundation reference set

Back to Start